Part one of these three-part series on addressing racism in pain research offers historical and theoretical background, as well as proposed shifts in language and practices in pain research frameworks, to promote the incorporation of antiracism research practices.
Veterans and Caregivers are invited to submit abstracts for poster presentations that highlight research projects, Veteran Engagement Groups (VEGs), or other research-related activities. Posters sessions provide an opportunity meet researchers, other Veterans, and Caregivers from all over the United States. Accepted posters will be displayed during a poster session.
The NSCAP assesses the frequency, targeted outcome (e.g., “to manage pain”), perceived effectiveness, and setting of these approaches.
An early challenge was to ensure that PMC researchers across the 11 national, large-scale pain trials did not co-enroll participants in multiple, concurrent pain trials. Learn about the strategies developed to address this challenge.
In Learn as You Go (LAGO) study designs, the components of the complex package are repeatedly optimized in pre-planned stages, until the intervention package is optimized. In this manuscript, the authors explore the key features of the LAGO’ design, illustrated by the null BetterBirth study, a large-scale public health intervention trial. (DRAFT)
The 5-item PMC COVID-19 measure assesses five potential domains of pandemic impact: access to healthcare, social support, finances, ability to meet basic needs, and mental or emotional health. Two additional items assess infection status (personal and household) and hospitalization.
In surveys of patients with chronic pain, pain intensity is described as a critically important dimension of the pain experience and a crucial target of pain treatments (Turk et al., 2008). Moreover, panels of pain experts have suggested that “For most clinical trials of chronic pain treatments, a measure of pain intensity will provide the primary outcome measure.”
The International Association for the Study of Pain and ICD diagnoses of chronic pain use a minimum 3-
month threshold for establishing chronicity. For clinical trials
of treatments for chronic pain, IMMPACT recommends a 6-month minimum for pain duration, which we apply for this instrument.
The Patient Health Questionnaire-2 (PHQ-2) is a widely used, patient-reported, 2-item screening measure for depression.
The Alcohol Disorders Identification Test-Concise (AUDIT-C) is a brief alcohol use disorder screening instrument that reliably identifies individuals who are at risk for alcohol use disorder (including alcohol abuse or dependence).
